Clinical trial
GnRH Analogue for Ovarian Function Preservation in Hematopoietic Stem Cell…
NCT00429494 · M.D. Anderson Cancer Center, Other · Completed
Key facts
| NCT number | NCT00429494 |
|---|---|
| Title | GnRH Analogue for Ovarian Function Preservation in Hematopoietic Stem Cell Transplantation Patients |
| Official title | Phase II Study of GnRH Analogue for Ovarian Function Preservation in Hematopoietic Stem Cell Transplantation Patients |
| Lead sponsor | M.D. Anderson Cancer Center, Other |
| Collaborators | TAP Pharmaceutical Products Inc. Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Amenorrhea, Premature Ovarian Failure, Ovarian Function Insufficiency |
| Intervention type | Behavioral, Drug, Procedure |
| Interventions | Leuprolide Acetate, Questionnaire, Hematopoietic Stem Cell Transplantation |
| Enrollment | 60 |
| Start date | Nov 1, 2002 |
| Primary completion | Jun 1, 2011 |
| Completion | Jun 1, 2011 |
| First posted | Jan 31, 2007 |
| Last update posted | Jul 9, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: